1Sharkey J;Cantor AQ;Solc Z.Brachytherapy versus radical prostatectomy in patients with clinically localized prostate cancer,2002.
2Merrick GS;Butler WM;Galbreath RW.Five-year biochemical outcome following permanent interstitial brachytherapy for clinical T1-T3 prostate cancer,2001.
3Galalae RM;Kovacs G;Schultze J.Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer[J],2002.
4Merrick GS;Butler WM;Galbreath RW.Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confirmed carcinoma of the prostate gland[J],2002.
5Chen A;Galloway M;Landreneau R.Intraoperative 125 I brachytherapy for high-risk stage I non-small cell lung carcinoma[J],1999.
6Monge RM;Nag S;Nieroda CA.125 I odine brachytherapy in the treatment of colorectal adenocarcinoma metastatic to the liver[J],1999.
7Stannard C;Sealy R;Hering E.Localized whole eye radiotherapy for retinoblastoma using a 125 I applicator,claws[J],2001(2).
8Bodner WR;Hilaris BS.Brachytherapy and pancreatic cancer,1997.
2Lazarescu GR, Battista JJ. Analysis of the radiobiolo gy of Ytterbium-169 and Iodine-125 permanent brachytherapy implants[j]. Phys Med Biol, 1997,42:1727-1736.
3Ling CC. Permanent implams using Au-198, Pd-103and I-125: Radiobiological considerations based on the linear quadratic model [J]. Int J Radiat Oncol Biol Phys, 1992,23:81-87.
5Anderson LL, Kuan HM, Ding IY. Clinical dosimetry with I-125 [A]. In Gorge [ed]. Modern interstitial and intracavitary radation cancer management [C].New York : Masson Publishing, 1981.
6Williamson JF. Physics of brachythcrapy[A]. Perez CA, Brady LW[ed]. Principles and practice of radiation oncology [C]. Third Edition, Philadelphia: Lippincott -Raven, 1997.
7Nath R, Anderson LL, Meli JA, et al. Code of practice for brachytherapy physics: Report of the AAPM radation therpy committee task group NO. 56[J]. Med Phys, 1997,24:1557-1579.
8Wu A, Zwicker D, Sternick ES. Tumor dose specification of I-125 seed implants[J]. Med Phys, 1985,12:27-31.
9Chen Y, Stanton RE, Holst RJ, et al. Treatment planning for prostate implant with loose seeds [J].Med Phys,1997, 24:1141-1145.
10Nath R, Anderson LL, Luxton G, et al. Dosimetry of interstitial brachtherapy sources:Recommendations of the AAPM radiation therapy committee task group NO. 43[J]. Med Phys,1995, 22:209-233.
